NCT05439811

Brief Summary

The investigators aimed to investigate postoperative complications associated with Swan-Ganz Catheter based on the clinical data of Wuhan Union Hospital and Wuhan Asian heart hospital for 10 years, including major cardiovascular, respiratory adverse events, ICU time, mechanical ventilation time, length of hospital stay, in-hospital mortality, and 30-day postoperative mortality events.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2022

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 21, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 30, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

June 30, 2022

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

July 6, 2022

Status Verified

June 1, 2022

Enrollment Period

3 years

First QC Date

June 21, 2022

Last Update Submit

June 30, 2022

Conditions

Postoperative Complications

Keywords

Swan-Ganz CatheterCardiac SurgeryPostoperative complications

Outcome Measures

Primary Outcomes (2)

  • Number of participants with cardiovascular events

    1\) Cardiac death; 2) Non fatal myocardial infarction; 3) Intra aortic balloon counterpulsation (IABP); 4) Thoracotomy exploration; 5) Heart failure.

    one week after operation

  • Number of participants respiratory adverse events

    1\) Acute lung injury: Diagnosis according to Berlin diagnostic standard; 2) Atelectasis: X-ray confirmed with body temperature \>37.5c or abnormal pulmonary manifestations; 3) Pneumothorax: chest X-ray diagnosis; 4) Pneumonia: confirmed by radiology or bacteriology

    one week after operation

Interventions

Swan-Ganz CatheterPROCEDURE

Swan-Ganz Catheter

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adults undergoing cardiac surgery

You may qualify if:

  • Over 18 years old;
  • Patients undergoing major cardiac surgery under general anesthesia;
  • Patients with complete sex, age, use of floating catheter and prognosis data

You may not qualify if:

  • ASA grade V and above;
  • End stage renal disease requiring (or undergoing) renal replacement therapy;
  • Pregnant or lactating women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Postoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

June 21, 2022

First Posted

June 30, 2022

Study Start

June 30, 2022

Primary Completion

June 30, 2025

Study Completion

December 30, 2025

Last Updated

July 6, 2022

Record last verified: 2022-06